<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.hcplive.com/view/summit-substudy-reveals-tirzepatide-s-impact-on-lv-atrial-metrics-of-hfpef</loc>
      <lastmod>2026-11-20T19:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T19:30:00Z</news:publication_date>
        <news:title><![CDATA[SUMMIT Substudy Reveals Tirzepatide’s Impact on LV, Atrial Metrics of HFpEF]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/silent-mucus-plugs-in-copd-and-exacerbation-risk-with-emily-wan-md-mph</loc>
      <lastmod>2026-11-20T19:03:49.494Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T19:03:49.494Z</news:publication_date>
        <news:title><![CDATA[Silent Mucus Plugs in COPD and Exacerbation Risk, With Emily Wan, MD, MPH]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/viaskin-peanut-patch-peanut-allergy-biomarkers-vitesse</loc>
      <lastmod>2026-11-20T17:52:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T17:52:00Z</news:publication_date>
        <news:title><![CDATA[Viaskin Peanut Patch Shifts Peanut Allergy Biomarkers in VITESSE]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ai-enabled-cpa-with-ccta-associated-with-improved-ldl-c-better-goal-achievement</loc>
      <lastmod>2026-11-20T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T17:00:00Z</news:publication_date>
        <news:title><![CDATA[AI-Enabled CPA With CCTA Associated With Improved LDL-C, Better Goal Achievement]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/abcs-in-dermatology-evolving-therapies-and-dermatology-s-role-in-cutaneous-lupus-care</loc>
      <lastmod>2026-11-20T01:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T01:00:00Z</news:publication_date>
        <news:title><![CDATA[ABCs in Dermatology: Evolving Therapies and Dermatology's Role in Cutaneous Lupus Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/rapid-etripamil-converts-two-thirds-of-recurrent-psvt-episodes-after-ablation</loc>
      <lastmod>2026-11-19T22:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T22:00:00Z</news:publication_date>
        <news:title><![CDATA[RAPID: Etripamil Converts Two-Thirds of Recurrent PSVT Episodes After Ablation]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/metformin-may-lower-cardiac-dysfunction-risk-during-vegf-inhibitor-therapy</loc>
      <lastmod>2026-11-19T20:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T20:30:00Z</news:publication_date>
        <news:title><![CDATA[Metformin May Lower Cardiac Dysfunction Risk During VEGF Inhibitor Therapy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/single-annual-injection-produces-significant-and-sustained-lp-a-reductions</loc>
      <lastmod>2026-11-19T19:15:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T19:15:00Z</news:publication_date>
        <news:title><![CDATA[Single Annual Injection Produces Significant and Sustained Lp(a) Reductions]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/why-ckm-screening-starts-with-one-patient-with-david-van-wyck-md</loc>
      <lastmod>2026-11-19T17:33:15.952Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:33:15.952Z</news:publication_date>
        <news:title><![CDATA[Why CKM Screening Starts With One Patient, With David Van Wyck, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/building-trust-into-community-kidney-screening-with-david-van-wyck-md</loc>
      <lastmod>2026-11-19T17:00:57.440Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:00:57.440Z</news:publication_date>
        <news:title><![CDATA[Building Trust Into Community Kidney Screening, With David Van Wyck, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ruvonoflast-reduces-hscrp-inflammation-cvd-risk-with-downstream-effects</loc>
      <lastmod>2026-11-19T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Ruvonoflast Reduces hsCRP, Inflammation, CVD Risk With Downstream Effects]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/q-a-interpreting-pediatric-nemolizumab-data-ad-lawrence-eichenfield-md</loc>
      <lastmod>2026-11-19T15:56:43.865Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T15:56:43.865Z</news:publication_date>
        <news:title><![CDATA[Q&A: Interpreting Pediatric Nemolizumab Data for AD, With Lawrence Eichenfield, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hs-care-priorities-patient-reported-outcomes-trust-and-stigma</loc>
      <lastmod>2026-11-19T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[HS Care Priorities: Patient-Reported Outcomes, Trust, and Stigma]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/one-copd-exacerbation-too-many-vickram-tejwani-md</loc>
      <lastmod>2026-11-19T02:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T02:00:00Z</news:publication_date>
        <news:title><![CDATA[One COPD Exacerbation Is Too Many: Vickram Tejwani, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/matching-fsgs-therapy-to-disease-phase-with-astrid-weins-md-phd</loc>
      <lastmod>2026-11-18T20:46:45.360Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T20:46:45.360Z</news:publication_date>
        <news:title><![CDATA[Matching FSGS Therapy to Disease Phase, With Astrid Weins, MD, PhD]]></news:title>
      </news:news>
	</url></urlset>